acquired
Stage
2015
Founded
3
Investors
About
MiroBio develops antibodies and variants to stimulate specific immune cell signals, allowing it to harness the natural control mechanisms of the immune system for therapeutic benefit across a range of diseases, particularly autoimmune disorders.
Explore MiroBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.